...
机译:先进的实体肿瘤患者,我对新型抗表皮生长因子受体抗体研究GC11的第一类阶段研究
Department of Internal Medicine Seoul National University College of Medicine Seoul National;
Department of Internal Medicine Seoul National University College of Medicine Seoul National;
Department of Internal Medicine Seoul National University College of Medicine Seoul National;
Department of Internal Medicine Seoul National University College of Medicine Seoul National;
Department of Dermatology Seoul National University College of Medicine Seoul National University;
Department of Dermatology Seoul National University College of Medicine Seoul National University;
GC PharmaYongin Korea;
Division of Medical Statistics Medical Research Collaborating Center Seoul National University;
Department of Clinical Pharmacology and Therapeutics Seoul National University College of Medicine;
Department of Pathology Seoul National University College of Medicine Seoul National University;
Department of Internal Medicine Seoul National University College of Medicine Seoul National;
机译:先进的实体肿瘤患者,我对新型抗表皮生长因子受体抗体研究GC11的第一类阶段研究
机译:人源化抗表皮生长因子受体单克隆抗体EMD72000在患有表皮生长因子受体的晚期实体瘤患者中的研究。
机译:表皮生长因子受体指导的双特异性抗体MDX-447不含或含重组人粒细胞集落刺激因子的I期试验在晚期实体瘤患者中的应用
机译:HER1癌症治疗疫苗:一种针对表皮生长因子(EGF-R)受体的肿瘤的主动免疫疗法
机译:针对人表皮生长因子受体的生物仿制药嵌合单克隆抗体的克隆和表达及其在CHO细胞中的产生,用于治疗结肠直肠癌。
机译:新型抗表皮生长因子受体抗体GC1118在晚期实体瘤患者中的首次人体I期研究
机译:实体瘤患者抗表皮生长因子受体单克隆抗体的1期研究